Predictive Effect of TGF-β and INS-PI3K-AKT Related Proteins for POD in Diabetes Patients

NCT06426953 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2025-09-29

No results posted yet for this study

Summary

To investigate the relationship between POD, TGF-β and INS-PI3K-AKT signaling pathway related proteins (ADNP, MAP6, PGC-1α) in diabetic patients

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Xie Kangjie

    lead OTHER

Principal Investigators

  • Kangjie Xie, MD · Zhejiang Cancer Hospital

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-20
Primary Completion
2025-12-30
Completion
2026-08-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06426953 on ClinicalTrials.gov